Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Table S1 from The CD94/NKG2A–HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective
Home
Publications
Supplementary Table S1 from The CD94/NKG2A–HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective
Supplementary Table S1 from The CD94/NKG2A–HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective
Authors:
ML
Miguel López-Botet
Miguel López-Botet
CV
Carlos Vilches
Carlos Vilches
AM
Aura Muntasell
Aura Muntasell
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
16 March 2026
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1078-0432.31744875
Abstract
Summary of selected clinical trials assessing the safety/clinical efficacy of targeting NKG2A
Keywords
HLA-E AXIS
CANCER IMMUNOTHERAPY
SUPPLEMENTARY TABLE
CRITICAL PERSPECTIVE
PERSPECTIVE SUMMARY
TRIALS ASSESSING
SELECTED CLINICAL
CLINICAL TRIALS
CLINICAL EFFICACY
TABLE
Related articles
Scroll to top